Breaking News2 years ago
FDA approves Alzheimer’s treatment Leqembi, clearing the way for Medicare coverage
[ad_1] The U.S. Food and Drug Administration on Thursday granted full approval to the Biogen BIIB and Eisai Co. Ltd. ESALF Alzheimer’s treatment Leqembi, a step...
